Gossamer Bio, Inc. financial data

Symbol
GOSS on Nasdaq
Location
3115 Merryfield Row, Suite 120, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 491 % -29.4%
Debt-to-equity -1.09K % -330%
Return On Equity 594 %
Return On Assets -59.7 % -170%
Operating Margin -365 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 231M shares +2.14%
Common Stock, Shares, Outstanding 231M shares +2.08%
Entity Public Float 197M USD +101%
Common Stock, Value, Issued 24K USD +4.35%
Weighted Average Number of Shares Outstanding, Basic 228M shares +0.72%
Weighted Average Number of Shares Outstanding, Diluted 228M shares +0.72%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 44.1M USD +40.2%
General and Administrative Expense 36.1M USD +0.91%
Operating Income (Loss) -161M USD -121%
Nonoperating Income (Expense) 2.25M USD -49.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -48.2M USD -51%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -156M USD -118%
Earnings Per Share, Basic 0 USD/shares -518%
Earnings Per Share, Diluted 0 USD/shares -518%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.93M USD -68.6%
Marketable Securities, Current 171M USD -42.6%
Accounts Receivable, after Allowance for Credit Loss, Current 9.24M USD +40.3%
Assets, Current 204M USD -40.7%
Property, Plant and Equipment, Net 70K USD -76.8%
Operating Lease, Right-of-Use Asset 4.35M USD -27.7%
Other Assets, Noncurrent 407K USD +43.8%
Assets 209M USD -40.5%
Accounts Payable, Current 1.12M USD -63.5%
Employee-related Liabilities, Current 12M USD +19.7%
Accrued Liabilities, Current 19.3M USD +10.7%
Contract with Customer, Liability, Current 24M USD +17.9%
Liabilities, Current 62.1M USD +21.6%
Contract with Customer, Liability, Noncurrent 27.1M USD -38.1%
Operating Lease, Liability, Noncurrent 3.7M USD -19.4%
Liabilities 291M USD -1.88%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.11M USD -129%
Retained Earnings (Accumulated Deficit) -1.39B USD -12.6%
Stockholders' Equity Attributable to Parent -82.3M USD -252%
Liabilities and Equity 209M USD -40.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -39.7M USD +24%
Net Cash Provided by (Used in) Financing Activities 504K USD
Net Cash Provided by (Used in) Investing Activities 22.1M USD -64.2%
Common Stock, Shares Authorized 700M shares 0%
Common Stock, Shares, Issued 231M shares +2.08%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.1M USD -352%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.93M USD -68.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 229M USD +3.29%
Deferred Tax Assets, Gross 230M USD +3.43%
Operating Lease, Liability 4.62M USD -27.2%
Payments to Acquire Property, Plant, and Equipment 26K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -159M USD -117%
Lessee, Operating Lease, Liability, to be Paid 5.87M USD -28.5%
Property, Plant and Equipment, Gross 193K USD -97.3%
Operating Lease, Liability, Current 919K USD -47.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.41M USD +0.64%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.42M USD -6.72%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.25M USD -33%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.45M USD +2.99%
Deferred Tax Assets, Operating Loss Carryforwards 97.9M USD -20.4%
Unrecognized Tax Benefits 13.9M USD +1.94%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.24M USD -14.6%
Operating Lease, Payments 2.7M USD -22.9%
Depreciation, Depletion and Amortization 580K USD -58.6%
Share-based Payment Arrangement, Expense 12.6M USD -54.6%
Interest Expense 13.1M USD -5.56%